Desire, done right
Sexual desire research that actually made it through clinical approval — for one specific use
How strong is the science here?
Backed by solid human trials, or used as an approved medicine for specific conditions.
Probably not your path if…
- Treating a random "PT-141 research vial" as the approved drug
- Ignoring who the approved medicine is actually for
- Expecting it to work like Viagra (different pathway)
Compounds to explore
Who this is for
You want the evidence-literate version of the desire peptides — including the fact that a real, approved medicine exists here for a narrow use.
How to think about it
PT-141 (bremelanotide) works on the brain's desire pathway, not on blood flow like Viagra, and it's approved as Vyleesi for one specific diagnosis — with real trial data and real side effects. The key distinction: pharmacy bremelanotide is not the same as a random gray-market vial. Kisspeptin-10 is an earlier-stage compound being studied for the hormones behind desire.
Start here
Read the Desire & Drive stack and the PT-141 page, then the About page on why approved products differ from research vials.
Clues that match this profile
We’ll use these later for a short guided quiz.
- Main goal is libido or sexual desire
- Wants clinically studied options
- Curious how research peptides differ from approved drugs